One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage Plus membership.
Explore Editage Plus
Audio Papers
Ask R Discovery
Translation
Auto-sync
Collaboration
https://doi.org/10.1182/blood.v126.23.831.831
Copy DOI
Export
Save
Share
Cite Journal: Blood |  Publication Date: Dec 3, 2015 |
Affiliation: The Ohio State University, Vifor Pharma (United States), Huntsman Cancer Institute, University of Utah, Dana-Farber Cancer Institute, IJ Research (United States), St James's University Hospital, Presbyterian Hospital, Cornell University, University of Oxford, Istituti di Ricovero e Cura a Carattere Scientifico, Vita-Salute San Raffaele University, The University of Texas MD Anderson Cancer Center, University of California, Irvine, King's College Hospital NHS Foundation Trust, Northwest Medical Specialties
The Bruton Tyrosine Kinase (Btk) Inhibitor ACP-196: Marked Activity in Relapsed/Refractory CLL with a Favorable Safety Profile
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
